Hopital Gui de chauliac

Montpellier 34295

0 studies enrolling now · 11 studies all time

What they study most

Acute Ischemic Stroke, Alzheimers Disease, Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Aneurysmal Subarachnoid Hemorrhage, HIV Infections, HIV-1, Huntington Disease, Idiopathic Hypersomnia, Ischemic Stroke; Ischemic Attack, Transient, Progressive Multiple Sclerosis (PMS)

Studies at this site

• A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease — Recruiting now
• A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE — Running, not enrolling
• A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis — Running, not enrolling
• GENERATION HD2. A Study to Evaluate the Safety, Biomarkers, and Efficacy of Tominersen Compared With Placebo in Participants With Prodromal and Early Manifest Huntington's Disease — Running, not enrolling
• A Multicenter Study of the Efficacy and Safety of JZP-258 in the Treatment of Idiopathic Hypersomnia (IH) With an Open-label Safety Extension — Completed
• A Study for Patients Who Completed VITALITY-ALS (CY 4031) — Completed
• Ventilatory Investigation of Tirasemtiv and Assessment of Longitudinal Indices After Treatment for a Year — Completed
• Clazosentan in Aneurysmal Subarachnoid Hemorrhage — Stopped early
• Expanded Access Program for Maraviroc At Multiple Centers — Completed
• Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1 — Stopped early
• Efficacy and Safety Study of DP-b99 in Treating Acute Ischemic Stroke — Stopped early